BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30410586)

  • 1. S100A4-MYH9 Axis Promote Migration and Invasion of Gastric Cancer Cells by Inducing TGF-β-Mediated Epithelial-Mesenchymal Transition.
    Li F; Shi J; Xu Z; Yao X; Mou T; Yu J; Liu H; Li G
    J Cancer; 2018; 9(21):3839-3849. PubMed ID: 30410586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis.
    Zhang X; Zhang P; Shao M; Zang X; Zhang J; Mao F; Qian H; Xu W
    Cancer Manag Res; 2018; 10():4459-4470. PubMed ID: 30349378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
    Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
    Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A4 amplifies TGF-β-induced epithelial-mesenchymal transition in a pleural mesothelial cell line.
    Ning Q; Li F; Wang L; Li H; Yao Y; Hu T; Sun Z
    J Investig Med; 2018 Feb; 66(2):334-339. PubMed ID: 29141874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer.
    Wang B; Qi X; Liu J; Zhou R; Lin C; Shangguan J; Zhang Z; Zhao L; Li G
    J Cancer; 2019; 10(4):874-884. PubMed ID: 30854093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated miR-296/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer.
    Yan W; Chen J; Chen Z; Chen H
    Am J Cancer Res; 2016; 6(2):260-9. PubMed ID: 27186401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.
    Techasen A; Namwat N; Loilome W; Duangkumpha K; Puapairoj A; Saya H; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):703-11. PubMed ID: 24867797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
    Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
    Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
    He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C
    BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
    Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein and activin membrane-bound inhibitor overexpression inhibits gastric tumor cell invasion via the transforming growth factor-β/epithelial-mesenchymal transition signaling pathway.
    Yuan CL; Liang R; Liu ZH; Li YQ; Luo XL; Ye JZ; Lin Y
    Exp Ther Med; 2018 Jun; 15(6):5422-5430. PubMed ID: 29805551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2.
    Xu H; Li M; Zhou Y; Wang F; Li X; Wang L; Fan Q
    Tumour Biol; 2016 Mar; 37(3):2925-32. PubMed ID: 26409452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
    Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
    J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector.
    Chen D; Zhang R; Shen W; Fu H; Liu S; Sun K; Sun X
    Int J Oncol; 2013 May; 42(5):1763-9. PubMed ID: 23546393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9-induced deubiquitination of β-catenin to block gastric cancer metastasis.
    Liu J; Liu Z; Yan W; Yang H; Fang S; Deng S; Wen Y; Shen P; Li Y; Hou R; Liu X; Huang T; Li R; Zheng D; Liu Z; Fang W
    MedComm (2020); 2022 Dec; 3(4):e185. PubMed ID: 36448053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of S100A4 in the epithelial-mesenchymal transition of esophageal squamous cell carcinoma and its molecular mechanism].
    Jian L; Zhihong W; Liuxing W; Qingxia F
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):258-65. PubMed ID: 26462889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
    Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
    J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.